Drug Patents owned by Maia Pharms Inc

1. List of Sincalide drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11318100 MAIA PHARMS INC Storage stable sincalide formulations
Apr, 2038

(14 years from now)

US11110063 MAIA PHARMS INC Storage stable sincalide formulations
Apr, 2038

(14 years from now)

Do you want to check out SINCALIDE patents from before 2022?

Drugs and Companies using SINCALIDE ingredient

Market Authorisation Date: 22 November, 2022

Treatment: Accelerate the transit of a barium meal through the small bowel, thereby decreasing the time and extent of radiation associated with fluoroscopy and x-ray examination of the intestinal tract; Stimulat...

Dosage: POWDER;INTRAVENOUS

More Information on Dosage

SINCALIDE family patents

5

United States

1

Canada

1

European Union

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in